| Online View |
|
|
 |
|
Wednesday,
August 7th, 2024 2PM CT / 3PM ET |
| Hosted by: Sino Biological & GenioBioTx |
 |
在本次 Lock & Key 網路研討會中，GenoBioTx 的 Dr. Hua Wei 將探討抗體藥物偶聯療法的最新進展。
近年來，抗體藥物偶聯物（ADC）療法取得了令人鼓舞的成果，已有15種ADC被FDA核准用於治療各種惡性腫瘤。這些標靶療法將所需的抗原特異性與小分子細胞毒性有效負荷的效力結合起來。然而，在實現 ADC 的全部臨床潛力之前，必須解決幾個問題，特別是與治療實體腫瘤時的抗藥性和毒性相關的問題。最新進展表明，除了優化 ADC 的抗體、接頭和有效負載外，ADC 的臨床前模型對於評估和提高抗腫瘤功效也很重要。
這場網路研討會是與 GenoBioTx合作舉辦的
GenoBioTx |
Key Learnings:
• ADC, Preclinical Models, bsADCs |
|
| Speaker: |
 |
Dr.
Hua Wei
VP of Industrial Clients Department, GenoBioTx/Shanghai Model Organisms Center |
Dr. Wei, Vice President of the Industrial Clients Department of Shanghai Model Organism Center
(USA). He has extensive drug development and preclinical research experience in molecular biology,
immunology, and animal models. He received his Bachelor and Master of Science degrees from China
Agricultural University. In 2008, Dr. Wei received his Ph.D. in Biochemistry from Ohio State
University. In 2009, he began postdoctoral training in MD Anderson Cancer Center. In 2012, Dr. Wei
served as a principal investigator at the National Human Genome Research Center in Beijing.
Subsequently, he joined several biotechnology and biopharmaceutical companies such as Gloria
Biosciences, Artivila Biopharma as preclinical director, and senior preclinical director. He was
responsible for preclinical research on antibody and small molecule drugs, and one drug was
successfully approved in 2022 and another drug was approved for clinical trials by the NMPA. In
mid-2022, he joined GenioBioTx in Houston, TX. |
|
The information and opinions provided by speakers as well as Sino Biological employees during
hosted webinar series are solely of their own and Sino Biological assumes no responsibility or
liability for this content. |
|
|
Watch
Our Previous Webinars on Demand Here
 |
|
| About Sino Biological |
Sino
Biological specializes in antibody development and recombinant protein production. All of Sino
Biological’s products are developed and produced in-house. Sino Biological also offers pharmaceutical
companies and biotechnology firms a variety of recombinant production and assay services for pre-clinical
research development. |
|
|
To make sure you keep getting these
emails, please add supports@marketing.sinobiologicaledm.com to your address book or whitelist us. Want out
of the loop? Unsubscribe. |
